Engineered Polymers for siRNA Therapy of COVID-19

Coronavirus disease 2019 (COVID-19) has emerged as a major threat to life on earth. COVID-19 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The excessive reaction displayed by immune system against this virus is damaging particularly to lungs, resulting in rapid lung failure and loss of life. We propose to develop a new method to eradicate viral load in COVID-19 patients. We will develop specific drugs and deliver them into lungs in order to stop viral replication, to ease the symptoms of VOCID-19 and cure the disease.

Non-Viral Approach to Immunotherapy with Engineered Polymers

A new therapy was developed in order to combat cancers by stimulating our immune system to fight agents the cancer cells in the body. The activated immune system is more efficient to fight the cancer cells than the common drugs, but stimulating the immune system is very expensive and labour-intensive with the currently developed protocols. This project will develop a cost-effective way to stimulate immune system to fight cancers. We will use advanced biomaterials and immune stimulatory genes in order to achieve this.